Designation of 11 new B.1 sublineages #45
Merged
Add this suggestion to a batch that can be applied as a single commit.
This suggestion is invalid because no changes were made to the code.
Suggestions cannot be applied while the pull request is closed.
Suggestions cannot be applied while viewing a subset of changes.
Only one suggestion per line can be applied in a batch.
Add this suggestion to a batch that can be applied as a single commit.
Applying suggestions on deleted lines is not supported.
You must change the existing code in this line in order to create a valid suggestion.
Outdated suggestions cannot be applied.
This suggestion has been applied or marked resolved.
Suggestions cannot be applied from pending reviews.
Suggestions cannot be applied on multi-line comments.
Suggestions cannot be applied while the pull request is queued to merge.
Suggestion cannot be applied right now. Please check back later.
Transmission of descendants of the 2022 outbreak lineage B.1 is ongoing in 2024. The new lineage designations aim to capture current circulation (since July 2024), most of which has been concentrated into B.1.20 and C.1.1 - at least based on publicly available genomes which are predominantly from the US, Germany, Portugal, and Australia.
The newly designated lineages are B.1.23; D.1 (B.1.6.1); E.1, E.2, E.3 (all children of C.1.1); and F.1, F.2, F.3, F.4, F.5, and F.6 (children of B.1.20). With these designations, the B.1 descendants are more clearly distinguished from each other.
D.1 (B.1.6.1) is from #41
F.1 (B.1.20.1) is from #40
F.2 (B.1.20.2) is from #39
E.1-3 (C.1.1.1-3) are from #44
B.1.23 is from #43